FDA Drugs recall ·
Bimatoprost recall
- Recall number
- D-0260-2025
- Date
- (initiated February 7, 2025)
- Company / brand
- Aspen Biopharma Labs Pvt., Ltd.
Plot No 10, Biotech Park Phase-II, Medchal Malkajgiri, India - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 400.0 gm
- Hazard tags
- Manufacturing practices (cGMP)
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.
Why was it recalled?
CGMP Deviations
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot Numbers: HABTC0020123, exp. date Dec-2026 HABTC0050623, exp. date May-2027 HABTC0091023, exp. date Sep-2028
Distribution
Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
States: Florida
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0260-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.